Multimodal treatment of locoregionally advanced breast cancer
β Scribed by G. N. Hortobagyi; G. R. Blumenschein; W. Spanos; E. D. Montague; A. U. Buzdar; H.-Y. Yap; F. Schell
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 568 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background and Objectives: The 1990s have established the contribution of multimodality therapy in the management of IIIb noninflammatory breast cancer (IIIb NIBC), by reducing the odds of recurrence and death. Methods: A total of 300 women with IIIb NIBC received a multimodality therapy. The treatm
The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the